- Email: [email protected]
Volume 32, 1993 author and keyword index
BULLETIN Incorporating Journal of Electrophysiological Techniques
VOLUME 32,1993 AUTHOR AND KEYWORD INDEX
Pergamon Press New York l Oxford l Seoul
l
Tokyo
Editor-in-Chief MATTHEW
J. WADER
Division of Life Sciences, The Unive~it~ of Texas at San Antonio, 6900 North Loop 1604 West, San Antonio, Texas 78249-0662 Editorial
ANDERS BJGRKLUND, University of Lund, Lund, Sweden LARRY L. BUTCHER, University of California, Los Angeles, CA TERRY M. DWYER, University of Mississippi Medical Center, Jackson, MS DAVID L. FELTEN, University of Rochester Medical Center, Rochester, NY H. C. FIBIGER, The University of British Columbia, Vancouver, B.C., British Columbia, Canada FRED H. GAGE, University of California, San Diego, La Jolla, CA DWIGHT C. GERMAN, University of Texas Southwestern Medical Center, Dallas, TX GLENN I. HATTON, University of California, Riverside, CA MILES HERKENHAM, National Institute of Mental Health, Bethesda, MD DAVID M. JACOBOWITZ, Department of Health & Human Services, Bethesda, MD BARRY L. JACOBS, Princeton University, Princeton, NJ ABBA J. KASTIN, Veterans Administration Medical Center, New Orleans, LA KIYOSHI KATAOKA, The University of Ehime School of Medicine, Shigenobu, Onsen-Gun, Ehime, Japan HENRY KHACHATURIAN, National Institute of Mental Health, Rockville, MD S. T. KITAI, University of Tennessee, Memphis, Memphis, TN EDMUND F. LA GAMMA, Children’s Medical Center at Stony Brook, Stony Brook, NY JOHN C. LIEBESKIND, The University of California, Los Angeles. CA JAMES M. LIPTON, University of Texas Southwestern Medical Center, Dallas, TX SAMUEL M. MCCANN, University of Texas Southwestern Medical Center. Dallas, TX
Advisory
Board
RICHARD B. MAILMAN, University of North Carolina School of Medicine, Chapel Hill. NC PETER J. MORGANE. Worcester Foundation for Experimental Biology, Shrewsbury, MA ROBERT D. MYERS, East Carolina University School of Medicine, Greenville, NC DWIGHT M. NANCE, University of Manitoba, Winnipeg, Manitoba, Canada ANDRES NEGRO-VILAR, Department of Health & Human Services, Research Triangle Park, NC STYLIANOS NICOLAIDIS, College de France, Paris, France TAKETOSHI ONO, Toyama Medical and Pharmaceutical University, Toyama, Japan YUTAKA OOMURA, Yashiro-cho, Kato-gun, Hyogo, Japan MARY LOU OSTER-GRANITE, Unive~ity of California, Division of Biomedical Sciences, Riverside, CA DONALD W. PFAFF, The Rockefeller University, New York, NY PAUL R. SANBERG, University of South Florida College of Medicine, Tampa, FL MICHAEL T. SHIPLEY, University of Cincinnati Medical Center. Cincinnati, OH ALBERT SIMPSON, Showa University, Shinagawaku, Tokyo, Japan THEODORE SLOTKIN, Duke University Medical Center, Durham, NC L. W. SWANSON, University of Southern California, Los Angeles, CA TIMOTHY J. TEYLER, No~heastern Ohio Unive~ities College of Medicine, Rootstown, OH CHARLES D. WOODY, University of California at Los Angeles, Los Angeles, CA IAN S. ZAGON, M. S. Hershey Medical Center, Hershey, PA
BRAIN RESEARCH BULLETIN Production Editor. Susan Rosenthal, Pergamon Press, Tarrytown, NY Pliblis~ing, ~~ibs~r~~~~onand advertising Q$ices: Pergamon Press Inc., 660 White Plains Road, Tarrytown, NY 10591-5 153. USA, INTERNET “PPI~P~RGAMON.COM” and Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, England Published 18 per annum (monthly with 2 issues published in January, February, March, April, July, and September) iilnnual institutional subscription rate ( 1993): f740 (US$ I 184.00) Sterling prices are definitive. US dollar prices are quoted for convenience only, and are subject to exchange rate fluctuation. Prices include postage and insurance and are subject to change without notice.
Brain Research Bulletin, Vol. 32, pp. 695-700, Printed in the USA. All rights reserved.
1993
Copyright0
036L9230/93 $6.00 + .OO 1993 Pergamon Press Ltd.
AUTHOR INDEX Abdel-Rahman, A. A., 407 Adachi, A., 525, 531 Afonso, D., I1 Agarwal, R. K., 285 Aguirre, J. A., 639 Aihara, N., 517 Alburges, M. E., 97 Aldana, A., 467 Alexiuk, N. A. M., 433 Andrews, C. O., 4 19 Arai, T., 593 Arai, Y., 635 Argiolas, A., 7 I Babcock, A. M., 373 Bailhache, T., 273 Baker, D. A., 373 Bahhazart, J., 273 Banks, M., 477 Barbagli, B., 6 11 Barraco, R. A., 46 I Barton, C., 629 Barwick, V. S., 75 Baskin, D. G., 379 Bauer, R. M., 673 Baum, M. J., 185 Bellinger, L. L., 549 Beltramo, M., 123 Bern, T., 235,241 Beninger, R., 339 Bents&, K., 425 Bernardini, J., 543 Bigler, E. D., 345 Bilkey, D. K., 1 I3 Binemann. D.. 329 Blaier, D.: 345 Block, C. H., 207 Boegman, R. J., 339 Bohus, B., 573 Boswell, T., 379 Bowman, E. R., 23 Bray, G. A., 191, 537 Brownfield, M. S., 567 Brudzynski, S. M., 395 Buccafusco, J. J., 35, 681 Buchanan, K. L., 29 Bult, A., 623 Burr, R. B., 345 Bylund, D. B., 97 Cahill, D. W., 493 Calas, A., 123 Calka, J., 207 Cancedda, E., 647 Carnes, M., 567 Castonguay, T. W., 543 Catania, A., 3 I 1 Chambert, G. M., 525 Chandna. V. K.. 285 Chau, A.: 43 Chen, X. H., 661 Chung, Y. H., 365 Claustrat, B., 6 1 I Coenders, C. J. H., 7 Cooper, A. L., 223 Corda, M. G., 647 Coveiias, R., 639
Cridland, R. A., 201 Crim, J. W., 419 Cruz-Morales, S. E., 52 I Cullum, C. M., 325 Currie, P. J., 133
Hahock, N. L., 373 Hanesworth, J. M., 497 Haour, F., 25 I Harding, J. W., 497 Hartle, D. K., 419 Havens, M., 9 I Hawkins, M. F., 629 Hemandez, A., 685 Heynen, A. J., 113 Hiestand. L.. 623 Higginson, C., 497 Higuchi, M., 103 Higuchi, T., 453 Hiltz, M. E., 31 I Homma, I., 65, 267 Horn, E. M., 673 Hou, Z.-L., I79
D’Alessio, D. A., 379 D’istria, M., 257 Dagnault, A., 689 Dajas, F., 17 I Dar, M. S., 23 Dartois, E., 25 1 Davies. B. T.. 443 De Las Hems, S., 35 1 De Leon, M., 639 De Luca, B., 257 De Saint Hilaire, Z., 87 Deems, D. A., I Dell’anna. M. E.. 159 Diaz Del Guante, M. A., 521 DiCarlo, B., 443 Dorman, R. V., 437 Drumheller, A., 487 Dunbar, J. C., 46 I
Ikarashi, Y., 593 Imai, E., 615 Ingles, J. L., 339 Ishimaru. H.. 593 Itoh, M.,‘66 i Iwase, M., 267
I
Janz, L., 58 I Jhamandas, K., 339 Jolicoeur, F. B., 487 Jtirgens, U., 143
Emerich, D. F., 477 Engelking, L. R., 285 Ergene, E., 46 1 Erskine. M. S., 447 Erwin, L., 68 I Estrada-Palma, L. Y., 467
Kaakkola, S., 667 Kakeyama, M., 635 Kalant, H., 43 Kamara, K., 543 Kamei. C.. 365 Kannan, H., 453 Kashiwagi, M., 65 Kastinn. N. W.. 201 Kawawi, T., 6 i 5 Kedzie, K. A., 293 Kemah, D., 257 Kenagy, G. J., 379 Kerbusch, S. M. L., 7 Khanna, J. M., 43 Kienast, S. G., 399 Kirby, M. A., 29 Kobashi, M., 525 Koide, K., 5 17 Koizumi, T., 635 Kokkinidis, L., 56 1 Kondo, Y., 635 Kong, R. M., 385 Koolhaas, J. M., 573 Koutouzis, T. K., 493 Kozora, E., 325 Krieger, M., 123 Krueger. P.. 477 Kubo, M., 103 Kuchk, S., 2 I 1 Kumar, M. S. A., 285 Kumar, V. M., 153 Kumazaki, M., 517 Kurokawa, M., 555
Fadden, C., 399 Figlewicz, D. P., 425 Fillion. G.. 25 I Flynn,‘F. W., 91 Franzoni, M. F., 123 Freeman. T. B.. 493 Fregly, M. J., 39 I Fry%, B., 477 Fuiise. T.. 555 Fukagawa, K., 555 Fukuda, M., 227 Fukunaga, H., 615 Fukuuchi, Y., 49 Funahashi, M., 53 1 Furuya, R., 6 I5 Gag& M. A., 487 Gale, S. D., 345 Gandia, J. A., 35 1 Garcia, M., 351, 521 Garcia-Austt, E., 17 I Gaztelu, J. M., 171 Gelowitz, D. L., 561 Gereau, R. W., IV, 293 Gietzen. D. W., 549 Gimenez-Amaya, J. M., 35 1 Giorgi, O., 647 Giuditta, A., 503 Goldberg, E., 32 1 Gomi, S., 49 Gonzalez-Baron, S., 639 Gbrska, T., 235, 241 Greenberg, A. H., 58 I Guevara-Guzmin, R., 467 Guiditta, A., 503
Levy, A., 385 Li, C., 23 Li, W., 681
695
Lieberman, H. R., 385 Lightbown, K., 285 Lindqvist, E., 159 Lipton, J. M., 31 I Liu, R.-H., 179 Lorke, D. E., 215 Lovec, R., 373 Lu, C.-L., 143 Luiten, P. G. M., 601 Luthman, J., 159 Lynch, C. B., 623 Lynch, W. C., 373 Maj, M., 257 Majczyhski, H., 235,241 Manchanda, S. K., 153 Mandile, P., 503 Mares, P., 107 Marquette, C., 25 1 Maruno, M., 103 Maruyama, Y., 593 Marzalkowski. J.. 477 Mathian, B., 6 I 1’ Matsui, Y ., 6 15 Matsuzawa, Y., 191 McCook, E. C., 359 McDermott, P., 477 Melis, M. R., 71 Miachon, S., 6 I I Mihara, B., 49 Miki, T., 66 1 Miller-Wing, A. V., 497 Minerbo, G., 32 1 Mio, M., 365 Mitsuhashi, H., 103 Miyoshi, S., 66 1 Mogenson, G. J., 395 Montagnese, P., 503 Monteleone, P., 257 Morato, G. S., 43 Morien,_A., 443 Moses, S., 2 11 Moyse, E., 25 I Myers, R. D., 17, 75 Nagai, H., 5 17 Nagata, E., 49 Nakai, Y., 267, 3 15 Nakata, M., 555 Nance, D. M., 581 Narvkz, J. A., 639 Negoro, H., 453 Nicolaidis, S., 87 Niedermauntel, W., 2 15 Niijima, A., 103 Nishino, H., 227, 517 Nogawa, S., 49 Nolan, P. C., 673 Norman, A. B., 493 Nozaki, H., 49 Ocrant, I., 425 Ohya, A., 6 15 Okui, Y., 103 Olson, L., 159 Onimam, H., 65 Ono, T., 227
INDEX
696
Ouerghi, D., 689 Overstreet, D. H., 47 1
Rybosova, Z., 2 I I
Paeile, C., 685 Papa, M., 509 Pavcovich, L. A., 83 Peccia, J. C., 373 Pellicano, M. P., 509 Perez, H., 685 Pohl, M., 107 Popelier, M., 25 I Porter, J. P., 653 Prado-Alcala, R. A., 521 Pucilowski, O., 47 I Pundt, L. L., 97
Sadile, A. G., 503, 509 Sainsbury, R. S., 113 Sakata, T., 555 Sakurai, T., 5 17 Sanberg, P. R., 477,493 Sanchez-Arroyos, R., 17 I Santana, C., 11 Satoda, T., 66 I Saydoff, J. A., 567 Schoorlemmer, G. H. M., 573 Schormair. C.. 329 Schulkin, J., 91 Schwartz, M. W., 379 Seidl, J., 107 Seidler, F. J., 359 Serino, I., 257 Shaffer, M. J., 497 Shah, G., 43 Sharma, R., 153 Shinya, A., 6 I5 Shioda, S., 267 Shirai, T., 49 Shukitt-Hale, B., 385 Sipols, A. J., 379 Slotkin, T. A., 359 Smock, T., 321 Solano-Flares, L. P., 467 Sorensen, C. M., 58 I Soto-Moyano, R., 685 Speckmann, E.-J., 329 Spessert, R., 589 St.-Pierre, S., 487
Quirarte, G. L., 52 I Ramirez, 0. A., 83 Reite, M., 325 Rehon, J. K., 223 Renner, K. J., 293 Reyes, P. F., I Richard. D.. 689 Richardson,’ R. D., 379 Rivest, R., 487 Rochet, T., 6 11 Rockhold, R. W., 26 1 Rodriguez, M., I1 Roozendaal, B., 573 Rothwell, N. J., 223 Rowland, N. E.. 391 Ruiz, S., 685 Ruwe, W. D., 17
Steger, R. W., 399 Stillman, M. J., 385 Stocker, J., 325 Strain, G. M., 57 Strijbos, P. J. L. M., 223 Stuesse, S. L., 195 Suarez, M. G., 1 Surlemont, C., 273 Tabuchi, E., 227 Taguchi, H., 103 Takada, M., 301 Takahashi, A., 593 Takashima, S., 49 Takeuchi, Y., 66 1 Tanaka, K., 49 Tang, J.-S., I79 Tao, S., 407 Tasaka, K., 365 Teale, P., 325 Tedford, B. L., 57 Thibault, J., 123 Thorn, K. J.. 29 Tobet. S. A., 185 Tokunaga, K., 191 Tsuruoka, M., 6 I5 Ueta, Y., 453 Van Der Zee, E. A., 601,623 Vescia, S., 503 Vincens, M.. 25 1 Vollrath, L., 589 Vossen, J. M. H., 7 Vriend, C. Y ., 58 1
Vtiend, J. P., 433 Wadhwa, S., 153 Waldrop, T. G., 673 Wamsley, J. K.. 97 Wan, W., 581 Wang, Q.-P., 3 15 Watanabe, T., 3 I I Wayner, M. J., 467 Wehman, P. J., 443 Welzl. H.. 509 Williams, F. E., 549 Winn, S. R., 477 Wittkowski, W., 329 Woods, S. C.. 379 Wright, D. E., 497 Wright. J. W.. 497 Wu,M., 395 Wurtman, R. J., 667 Yamanouchi, K., 635 Yamashita. H.. 453 Yang, X.-H., 35, 681 Yellon, S. M., 29 Yoshimatsu, H., 555 Zaplana, J., I7 I Zawada, W. M., 17 Zeng, D., 195 Zhang, L., 437 Zhang, T., 26 1 Zhang, W. M.. 21 I Zhao, J.. 477 Zmyslowski, W., 235, 24 I
KEYWORD (-)-Cotinine, 23 (-)-Nicotine, 23 2-Deoxyghlcose, I7 1 5-ADMP, 275 5-HT, 133 5-HTZ, 87 5a-P&mane-3aol-20-one, 25 1 6_Hydroxydopamine, 153 8-(p-sulfophenyl) Theophylline, 407 5,7-Dihydroxytryptamine, 567 [?+TBPS binding, 25 1, 647 (Y-MSH,3 I 1 a-Adrenergic receptors, 97 o-Fluoromethylhistidine (FMH), 555 cut-Receptor, 97 cy,-Subtypes, 97 %A, 97 ozrl, 97 ~ZC> 97 AADC, 123 Acetylchohne, 35, 143, 339, 593 ACTH, 567,6 I 1 Adenosine, 407 Adenylate cyclase in developing brain, 359 Adrenal ahtcocorticoids. 537 Aging, 477 Alzheimer’s disease, 1 Amino acid deficiency, 549 Amino acid imbalance, 549 Amphetamine, 56 1 Amygdala, 301, 339, 561 Aneuploidy, 2 15 Angiotensin II, 497 Anaiotensin IV. 497 A&omycin, 17 Anoxia, 159 Antidepressants, 257 Apomorphine, 7 1, 47 1,487 Arachidonic acid, 437 Arcuate nucleus, 58 I Area postrema, 53 1 Aromatase, 273 Aromatic L-amino acid decarboxylase, 123 Arterial pressure, 673 Atropine, 35 Attention deficit hyperactivity disorder , 159 Auditory-evoked fields, 325 Autoradiographic technique, 25 I Autoradiography, 49, 91, 497 Autoreceptor, 385 fl-Adrenergic receptors, 257 &Carbolines, 647 fi-Endorphin, 26 I B6CBAF,/J vs. C57BL/6J mice, 57 BIllax,49 Baroreceptors, 407 Barrow, 285 Basal ganglia, 35 I Becuculine, 647 Behavioral activity, 573 Behavioral arousal, 509 Behavioral asymmetry, 11 Behavioral effects of neural transnlantation. 493 Behavioral habituation, 509
INDEX
Behavioral interactions, 23 Behavioral supersensitivity, 47 1 Benzodiazepines, 647 Biochemical asymmetry, 1I Bioelectric activity, 329 Blood pressure, 35, 407, 497 Body fat, 2 11 Body temperature, 17, 20 I Bombesin, 629 Brain lesion, 273 Brain neuronal histamine, 555 Brain regions, 68 1 Brain stem. 123. 153. 419. 581. 639 Brain, 35, i91, 215, 379, 567, 593 Buserehn, 689 c-Fos, 447, 509 c-Jun, 509 C-fiber excitabihtv. 685 CAI region, 113 Capsaicin, 685 Cardiorespiratory control, 46 I Cardiovascular, 653 Cat, 235, 241, 639, 673 Catecholamines, 153, 261, 273, 285 CCK, 53 1 CCK-8,453 Central amygdala, 573 Cerebellum, 2 15, 509,6 I5 Cerebral cortex, 107 Cerebral cortex of the rat, 647 Cerebral ischemia, 49, 223, 373 Cervix, 467 cGMP, 589 Choline oxidase, 593 Choline-free plasma (CFP) rat, 593 Cholinesterase inhibition, 68 I Chronic antidepressants, 47 1 Chronic electrophysiology, 32 1 Circadian rhythms, 29,623 Circumventricular organ, 4 I9 Clonidine, 133, 68 1 CNS, 285 Collaterahzation, 30 1 Coordination, 24 1 Copulation, 273 Core body temperatue, 629 Comu ammonis, 17 1 Cot-ticosterone, 573,6 11,629 Corticotropin-releasing factor, 689 Cycle (Asp-Phe), 667 Cycle (His-Pro), 667
D- and L-Nitro-arginine, 43 d-Tubocurarine, 17 1 Decerebration, 46 I Densitometric averages, I7 1 dentata, I7 1 Depth profiles, 113 Desmethyiimipramine, 153 Desipramine, 425,47 1 Development, 29, 107, 159, 2 15 Dexamethasone, effects on development of brain adenylate cyclase, 359 Diabetes. 399 Diabetic’rat, 46 I Diacylglycerol, 437
Discrimination learning, 7 Djungarian, 29 DOPAC, 667 Dopamine, 11, 159, 285, 301, 395, 433, 471, 477,53 I, 667 Dorsal hippocampus, 601 Dorsal medulla, 4 I9 Dorsal motor nucleus of the vagus, 525 Dorsal raphe nucleus, 3 15 Double immunostaining, 3 I5 Double Y-maze, 339 Double-labeling immunocytochemistry, 601 Drinking, 497 Drinking behavior, 26 I Drinking circuit, 39 I Dual lesions, 635 Eating speed, 555 EEG synchronization, 365 Efferent discharges, 103 Electrocoagulation, 365 Electroconvulsive shock, 257 Electron microscopy, 3 15 Enantiomers, 443 Endotoxin, 17 Enkephalin, 3 I5 Entorhinal cortex, I, 17 1 Epilepsy, 329 Epinephrine, 573 Estrogen, 689 Estrogen implants, 293 Ethanol, 23, 43 Evoked potentials, 107 Excitatory amino acids, 223, 673 Excitotoxin models, 493 Excitotoxins, 493 Exercise, 673 Extracellular dehydration, 39 I Facial nerve, 66 I Fascia, 17 1 Feeding, 87, 133, 543,629 Feeding behavior, 379 Female rat, 635 Fetal neural transplantation, 493 Fever of unknown origin, 75 Fever, 17 Fish oil, 223 Flash visual evoked potentials, 57 Flinders sensitive line. 47 1 fluid balance, 207 Fhiorescent tracers, 195 Foliation, 2 I5 Food choice, 543 Food consistency, 555 Food intake, 443,537, 543, 549,689 Fomix, 345 Forskolin, 49 Forskolin, effects on brain adenylate cyclase, 359 FOS, 447 Free choline, 593 Free fatty acids, 629 Fungus, 75 GABA, 143, 315, 517 GABAA receptor, 647
698
GAD, 60 1 Galanin, 379 Gastric branch, 103 Gastric distension, 525 Gastric mechanoreceptors, 525 Gastric vagus, 525 Gender differences. 325 Gene expression, 379, 509 Genetics, 537 Gilt, 285 Globus pallidus, 301, 35 1 Glucose, 53 I Glucose availabilitv. 629 Glucose-responsive neuron, 53 1 Glutamate, 143, 437 Gonadal steroids, 185, 285 Ground squirrel, 379 Guinea pig, 497 Guinea pig brain. 25 1 Haloperiodol, 7 Heart rate, 407, 573, 673 Hemispheric specialization, 325 Hepatic glucoreceptors, 525 Hepatic vagus, 525 Hibernation, 379 Hippocampal slice, I 13 Hippocampus, 171,329, 373,437,497, 509 Histamine, 143, 267, 365 Horseradish peroxidase, 329 Human, 345 Human hippocampus, 25 1 Huntington’s disease, 493 HVA, 667 Hyperphagia, I9 I Hyperthermia, 75 Hypothalamus, 17, 75, 207, 211, 267, 379, 399,425, 537,673 Hypothermia, 373,47 I, 629 ICS 205-930. 549 IL-2, 17 Immediate early genes, 509 Immunocytochemistry, 267, 273,639 Immunohistochemistry, 123 In vitro, 65, 113 In vivo microdialysis, 453 Infarct, 5 17 Inferior olive, 30 I Inflammation, 3 11 Inspiratory neuron, 65 Insulin, 425, 629 Insulin secretion, 46 I Interleukin- I, 17, 3 I 1 Intracellular dehydration, 39 1 Intracellular staining, 329 lntracerebral injection, 75 lntracerebroventricular, 23 Intrathecal, 653 Ischemia, 5 17 Isolation, 6 I I Isoproterenol, 257 K‘j. 49 Lateral cerebral ventricle, 629 Lateral reticular nucleus, 179 Lateral septum, 635 Lateralityi 325 Laterodorsal tegmental nucleus, I95 LC activity, 83 Learned helplessness, 83
INDEX
Learned irrelevance, 7 Lever press, 7 Lipopolysaccharide, 58 I Locomotion, 235, 24 1, 395 Locomotor activity, 47 1, 477, 56 I Locomotor parameters, 235, 241 Long-term DMI treatment, 83 Long-term habituation, 503 Long-term potentiation, 437 Lordosis inhibiting system, 635 Lordosis, 293, 635 Losartan potassium, 39 I Luteinizing hormone, 399 MlOO, 325 m2 Receptor, 385 Macronutrient selection, I33 Macrophage inflammatory protein-l (MIP-I), 17 Magnetic resonance imaging, 345 Magnetoencephalography, 325 Male, 29 Masseter muscle, 6 I5 Mating, 447 Meal duration, 555 Meal size, 555 Medial amygdala, 447 Medial frontoal cortex, I95 Medial preoptic area, 153 Medulla oblongata, 267 MEG, 325 Melatonin, 257, 433 Memory consolidation. 52 1 Memory, 345,497 Mesencephalic central gray, 635 Mesencephalic trigeminal nucleus (Me5), 555 Methoctramine, 385 Mice, 23, 31 1 Microdialysis, 385, 5 17, 667 Microdrive, 32 I Microinjection, 17, 75 Midbrain central grey, 293 Middle cerebral artery, 5 17 Modafinil. 87 Mongolian gerbil, 373 Monkey, 227, 66 1 Monkey cortex, 25 I Monoamines, 123, 159, 185 Monoamines and turnover, 6 11 Morphine, I79 Morphology, 329 Mossy fibers, 437 Motor activity, 509 Motor coordination, 477 Mouse, 2 I5 Mouse brain, 25 1 Mus domeskus, 623 Muscarinic acetylcholine receptor, 601 Muscarinic agonists, 589 Muscarinic receptors, 35, 385, 68 1 N-propylnorapomorphine, 487 NADPH-diaphorase, 207 Neocortex, 301, 509 Neonatal, 1I, 159 Nest-building behavior, 623 Neural grafting, 493 Neural nets, 509 Neuritic plaques, I Neurodegenerative disorders, 493 Neurofibrillary tangles, I Neurogenic fever, 75
Neuronal activity, 227 Neuronal firing, 407 Neuropathology, 1 Neuropeptide Y, 379,46 1 Neuropsychology, 325 Neurosecretion, 207 Neurotensin, 487 Neurotoxin, 273 Neutrophils, 3 1I Newborn rat, 65 Nicotine, 35 Nitric oxide, 43, 7 I NMDA, 65,653 NMDA agonist, 223 NMDA receptors, 43, 509 Nociception, 179 Nonassociative learning, 503 Noradrenaline, 87, 153, 159, 453 Norephedrine, 443 Norepinephrine transporter, 425 Norepinephrine, 133, 273,285, 399, 573, 589 Novelty, 509 Nucleus accumbens, 30 I, 395 Nucleus basalis magnocellularis, 339 Nucleus of the solitary tract, 525 Nucleus tractus solitarius. 407. 46 I ob/ob mice, 133 Obesity, 191, 537 Oleoyl-acetyl-glycerol, 437 Olfactory bulb, 1, 467 Olfactory cortex, 1 Olfactory tubercle, 301 Oncogene proteins, 58 1 Ontogenesis, 647 Operant bar-press behavior, 227 Osmotic, 567 Osmotic minipump, 201 Ovariectomy, 689 Over-reinforcement, 52 I Oxytocin, 7 I, 567, 573 Oxytocin-secreting neurons, 453 p-Aminoclonidine, 97 plodoclonidine, 97 Paraventricular, 207 Paraventricular nucleus, 19I, 453, 58 1, 653 Parkinson’s disease, 493 Parvalbumin, 60 1,639 Passive avoidance conditioning, 497 Passive avoidance learning, 52 I Passive avoidance task, 5 I7 Pattern reversal visual evoked potentials, 57 PD123319, 391 Penile erection, 7 I, 487 Pentylenetetrazol, 329 Peptide, 4 19 Periamygdaloid nucleus, I Periaqueductal gray, 143 Phenylpropanolamine, 443 Pheochromocytoma, 425 Phorbol, 49 Physostigmine, I7 I, 487 Picrotoxin, 25 I Pig, 285 Pineal gland, 257 Pineilia
ternata,
103
Plasma, 593 Pons, 267 Posterior pituitary, 433 Posttrial sleep, 503 Potentiation, 107
699
INDEX
Pre-inspiratory neuron, 65 Preoptic area, 75, 273, 447 Prepirifonn cortex, I Projection, 6 15 Proprioceptive sensation from the oral ca 555 Prostaglandin, 17 Protein Kinase C. 437 Protein synthesis,’ I7 Protooncogene peptides, 509 Puberty, 29 Putamen, 227 Pyrogens, 17, 75
Settraline, 47 1 Sex differences, 11, 9 I, 325 Sexual differentiation, 185 SHR, 261 Single-unit recording, 321 Sleep, 87 Sleep functions, 503 Sleep-wakefulness, 153 Sodium nitrourusside. 589 Somatostatin,* 60 1 Spatial novelty, 503 Spinal cord, 301, 66 1, 673, 685 Spinal lesions, 24 1 Spinal reflex, 685 Quinpirole, 395 Spontaneous hypertension[Sar’,Illes]Angiotensin II, 4 19 Rabbit, 267 Squirrel monkey, 143 Rapid tolerance, 43 Starvation, 543 Rat, 7, 11, 71, 75, 91, 107, 159, 171, 179, 211, Stereotypy, 487 223. 301. 315. 351. 453. 459. 467. 477. 497. Striatum, 49, 30 1, 5 17, 667 Stroke, 223 517; 531; 543; 615; 653; 685 Rat brain, 601 Subnucleus interpolaris, 6 15 Rat pinealocytes, 589 Subparafascicular nucleus, 30 I Reference memory, 339 Substantia nigra, 35 1 Renal nerve, 653 Sucrose, 26 1 Reproductive behavior, 467 Superior cervical ganglion, 66 1 Respiratory rhythm, 65 Superior colliculus, 195 Response strategy, 7 Support patterns, 235, 241 Reticular formation. 179. 365 Suprachiasmatic nucleus, 29, 623 Reticular thalamic nucleus, 35 1 Supraoptic, 207 Retinohypothalamic tract, 29 Supraoptic nucleus, 58 I RNA, 211 Sympathetic activity, 537 RSA, 113 Sympathetic fibers, 66 I Synchronized sleep, 503 Salt preferences, 9 1 Systemic progesterone, 293 Scopolamine, 339 Scopolamine-induced amnesia, 52 I Taste reactivity, 9 1 Second-messenger, 49 Telemetry, 20 1 Self-satisfaction, 543 Temperature, 75 Sensitization, 56 1 Temporal potentiation, 685 Sensory afferent pathway, 467 Temporomandibular joint, 6 15 Serotonin, 159,293, 471, 567 Thalamic afferents, 35 I Serotonim receptor antagonist, 549 Thalamus, 1, 365, 615
Theophylline, 407 Thermoregulation, 17, 75, 629 Theta rhythm, 171 Theta, 113 Thirst, 391 Tilt-plane, 43 Total liver denervation, 549 Transplantation, 5 17 Traumatic brain injury, 345 Trichosooron beiaelii. 75 Trigeminal, 6 I5 Trisomy 19,215 Tropisetron, 549 Tyrosine hydroxylase, 433 Ultrastructue, 267 Under-reinforcement, Uterus, 467
521
Vagina, 467 Vaginocervical stimulation, 447 Vagotomy, 46 1 Vagus nerve, 103 Vasopressin, 207, 567, 573, 623 Ventral septal area, 20 1 Ventrolateral medulla, 65 Ventromedial hypothalamic nucleus (VMH), 555 Ventromedial hypothalamus, 191, 293, 629 Vertebrates, 123 Visual stimulus, 227 Visuomotor, 227 Vocalization, 143 WGA-HRP, 66 1 Windup, 685 Wistar rat, 6 11 Working memory, 339 Yz receptors, 46 1 Yawning, 7 1,487 Zucker obese rat, 555
VOLUME 32,1993 AUTHOR AND KEYWORD INDEX
Pergamon Press New York l Oxford l Seoul
l
Tokyo
Editor-in-Chief MATTHEW
J. WADER
Division of Life Sciences, The Unive~it~ of Texas at San Antonio, 6900 North Loop 1604 West, San Antonio, Texas 78249-0662 Editorial
ANDERS BJGRKLUND, University of Lund, Lund, Sweden LARRY L. BUTCHER, University of California, Los Angeles, CA TERRY M. DWYER, University of Mississippi Medical Center, Jackson, MS DAVID L. FELTEN, University of Rochester Medical Center, Rochester, NY H. C. FIBIGER, The University of British Columbia, Vancouver, B.C., British Columbia, Canada FRED H. GAGE, University of California, San Diego, La Jolla, CA DWIGHT C. GERMAN, University of Texas Southwestern Medical Center, Dallas, TX GLENN I. HATTON, University of California, Riverside, CA MILES HERKENHAM, National Institute of Mental Health, Bethesda, MD DAVID M. JACOBOWITZ, Department of Health & Human Services, Bethesda, MD BARRY L. JACOBS, Princeton University, Princeton, NJ ABBA J. KASTIN, Veterans Administration Medical Center, New Orleans, LA KIYOSHI KATAOKA, The University of Ehime School of Medicine, Shigenobu, Onsen-Gun, Ehime, Japan HENRY KHACHATURIAN, National Institute of Mental Health, Rockville, MD S. T. KITAI, University of Tennessee, Memphis, Memphis, TN EDMUND F. LA GAMMA, Children’s Medical Center at Stony Brook, Stony Brook, NY JOHN C. LIEBESKIND, The University of California, Los Angeles. CA JAMES M. LIPTON, University of Texas Southwestern Medical Center, Dallas, TX SAMUEL M. MCCANN, University of Texas Southwestern Medical Center. Dallas, TX
Advisory
Board
RICHARD B. MAILMAN, University of North Carolina School of Medicine, Chapel Hill. NC PETER J. MORGANE. Worcester Foundation for Experimental Biology, Shrewsbury, MA ROBERT D. MYERS, East Carolina University School of Medicine, Greenville, NC DWIGHT M. NANCE, University of Manitoba, Winnipeg, Manitoba, Canada ANDRES NEGRO-VILAR, Department of Health & Human Services, Research Triangle Park, NC STYLIANOS NICOLAIDIS, College de France, Paris, France TAKETOSHI ONO, Toyama Medical and Pharmaceutical University, Toyama, Japan YUTAKA OOMURA, Yashiro-cho, Kato-gun, Hyogo, Japan MARY LOU OSTER-GRANITE, Unive~ity of California, Division of Biomedical Sciences, Riverside, CA DONALD W. PFAFF, The Rockefeller University, New York, NY PAUL R. SANBERG, University of South Florida College of Medicine, Tampa, FL MICHAEL T. SHIPLEY, University of Cincinnati Medical Center. Cincinnati, OH ALBERT SIMPSON, Showa University, Shinagawaku, Tokyo, Japan THEODORE SLOTKIN, Duke University Medical Center, Durham, NC L. W. SWANSON, University of Southern California, Los Angeles, CA TIMOTHY J. TEYLER, No~heastern Ohio Unive~ities College of Medicine, Rootstown, OH CHARLES D. WOODY, University of California at Los Angeles, Los Angeles, CA IAN S. ZAGON, M. S. Hershey Medical Center, Hershey, PA
BRAIN RESEARCH BULLETIN Production Editor. Susan Rosenthal, Pergamon Press, Tarrytown, NY Pliblis~ing, ~~ibs~r~~~~onand advertising Q$ices: Pergamon Press Inc., 660 White Plains Road, Tarrytown, NY 10591-5 153. USA, INTERNET “PPI~P~RGAMON.COM” and Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 OBW, England Published 18 per annum (monthly with 2 issues published in January, February, March, April, July, and September) iilnnual institutional subscription rate ( 1993): f740 (US$ I 184.00) Sterling prices are definitive. US dollar prices are quoted for convenience only, and are subject to exchange rate fluctuation. Prices include postage and insurance and are subject to change without notice.
Brain Research Bulletin, Vol. 32, pp. 695-700, Printed in the USA. All rights reserved.
1993
Copyright0
036L9230/93 $6.00 + .OO 1993 Pergamon Press Ltd.
AUTHOR INDEX Abdel-Rahman, A. A., 407 Adachi, A., 525, 531 Afonso, D., I1 Agarwal, R. K., 285 Aguirre, J. A., 639 Aihara, N., 517 Alburges, M. E., 97 Aldana, A., 467 Alexiuk, N. A. M., 433 Andrews, C. O., 4 19 Arai, T., 593 Arai, Y., 635 Argiolas, A., 7 I Babcock, A. M., 373 Bailhache, T., 273 Baker, D. A., 373 Bahhazart, J., 273 Banks, M., 477 Barbagli, B., 6 11 Barraco, R. A., 46 I Barton, C., 629 Barwick, V. S., 75 Baskin, D. G., 379 Bauer, R. M., 673 Baum, M. J., 185 Bellinger, L. L., 549 Beltramo, M., 123 Bern, T., 235,241 Beninger, R., 339 Bents&, K., 425 Bernardini, J., 543 Bigler, E. D., 345 Bilkey, D. K., 1 I3 Binemann. D.. 329 Blaier, D.: 345 Block, C. H., 207 Boegman, R. J., 339 Bohus, B., 573 Boswell, T., 379 Bowman, E. R., 23 Bray, G. A., 191, 537 Brownfield, M. S., 567 Brudzynski, S. M., 395 Buccafusco, J. J., 35, 681 Buchanan, K. L., 29 Bult, A., 623 Burr, R. B., 345 Bylund, D. B., 97 Cahill, D. W., 493 Calas, A., 123 Calka, J., 207 Cancedda, E., 647 Carnes, M., 567 Castonguay, T. W., 543 Catania, A., 3 I 1 Chambert, G. M., 525 Chandna. V. K.. 285 Chau, A.: 43 Chen, X. H., 661 Chung, Y. H., 365 Claustrat, B., 6 1 I Coenders, C. J. H., 7 Cooper, A. L., 223 Corda, M. G., 647 Coveiias, R., 639
Cridland, R. A., 201 Crim, J. W., 419 Cruz-Morales, S. E., 52 I Cullum, C. M., 325 Currie, P. J., 133
Hahock, N. L., 373 Hanesworth, J. M., 497 Haour, F., 25 I Harding, J. W., 497 Hartle, D. K., 419 Havens, M., 9 I Hawkins, M. F., 629 Hemandez, A., 685 Heynen, A. J., 113 Hiestand. L.. 623 Higginson, C., 497 Higuchi, M., 103 Higuchi, T., 453 Hiltz, M. E., 31 I Homma, I., 65, 267 Horn, E. M., 673 Hou, Z.-L., I79
D’Alessio, D. A., 379 D’istria, M., 257 Dagnault, A., 689 Dajas, F., 17 I Dar, M. S., 23 Dartois, E., 25 1 Davies. B. T.. 443 De Las Hems, S., 35 1 De Leon, M., 639 De Luca, B., 257 De Saint Hilaire, Z., 87 Deems, D. A., I Dell’anna. M. E.. 159 Diaz Del Guante, M. A., 521 DiCarlo, B., 443 Dorman, R. V., 437 Drumheller, A., 487 Dunbar, J. C., 46 I
Ikarashi, Y., 593 Imai, E., 615 Ingles, J. L., 339 Ishimaru. H.. 593 Itoh, M.,‘66 i Iwase, M., 267
I
Janz, L., 58 I Jhamandas, K., 339 Jolicoeur, F. B., 487 Jtirgens, U., 143
Emerich, D. F., 477 Engelking, L. R., 285 Ergene, E., 46 1 Erskine. M. S., 447 Erwin, L., 68 I Estrada-Palma, L. Y., 467
Kaakkola, S., 667 Kakeyama, M., 635 Kalant, H., 43 Kamara, K., 543 Kamei. C.. 365 Kannan, H., 453 Kashiwagi, M., 65 Kastinn. N. W.. 201 Kawawi, T., 6 i 5 Kedzie, K. A., 293 Kemah, D., 257 Kenagy, G. J., 379 Kerbusch, S. M. L., 7 Khanna, J. M., 43 Kienast, S. G., 399 Kirby, M. A., 29 Kobashi, M., 525 Koide, K., 5 17 Koizumi, T., 635 Kokkinidis, L., 56 1 Kondo, Y., 635 Kong, R. M., 385 Koolhaas, J. M., 573 Koutouzis, T. K., 493 Kozora, E., 325 Krieger, M., 123 Krueger. P.. 477 Kubo, M., 103 Kuchk, S., 2 I 1 Kumar, M. S. A., 285 Kumar, V. M., 153 Kumazaki, M., 517 Kurokawa, M., 555
Fadden, C., 399 Figlewicz, D. P., 425 Fillion. G.. 25 I Flynn,‘F. W., 91 Franzoni, M. F., 123 Freeman. T. B.. 493 Fregly, M. J., 39 I Fry%, B., 477 Fuiise. T.. 555 Fukagawa, K., 555 Fukuda, M., 227 Fukunaga, H., 615 Fukuuchi, Y., 49 Funahashi, M., 53 1 Furuya, R., 6 I5 Gag& M. A., 487 Gale, S. D., 345 Gandia, J. A., 35 1 Garcia, M., 351, 521 Garcia-Austt, E., 17 I Gaztelu, J. M., 171 Gelowitz, D. L., 561 Gereau, R. W., IV, 293 Gietzen. D. W., 549 Gimenez-Amaya, J. M., 35 1 Giorgi, O., 647 Giuditta, A., 503 Goldberg, E., 32 1 Gomi, S., 49 Gonzalez-Baron, S., 639 Gbrska, T., 235, 241 Greenberg, A. H., 58 I Guevara-Guzmin, R., 467 Guiditta, A., 503
Levy, A., 385 Li, C., 23 Li, W., 681
695
Lieberman, H. R., 385 Lightbown, K., 285 Lindqvist, E., 159 Lipton, J. M., 31 I Liu, R.-H., 179 Lorke, D. E., 215 Lovec, R., 373 Lu, C.-L., 143 Luiten, P. G. M., 601 Luthman, J., 159 Lynch, C. B., 623 Lynch, W. C., 373 Maj, M., 257 Majczyhski, H., 235,241 Manchanda, S. K., 153 Mandile, P., 503 Mares, P., 107 Marquette, C., 25 1 Maruno, M., 103 Maruyama, Y., 593 Marzalkowski. J.. 477 Mathian, B., 6 I 1’ Matsui, Y ., 6 15 Matsuzawa, Y., 191 McCook, E. C., 359 McDermott, P., 477 Melis, M. R., 71 Miachon, S., 6 I I Mihara, B., 49 Miki, T., 66 1 Miller-Wing, A. V., 497 Minerbo, G., 32 1 Mio, M., 365 Mitsuhashi, H., 103 Miyoshi, S., 66 1 Mogenson, G. J., 395 Montagnese, P., 503 Monteleone, P., 257 Morato, G. S., 43 Morien,_A., 443 Moses, S., 2 11 Moyse, E., 25 I Myers, R. D., 17, 75 Nagai, H., 5 17 Nagata, E., 49 Nakai, Y., 267, 3 15 Nakata, M., 555 Nance, D. M., 581 Narvkz, J. A., 639 Negoro, H., 453 Nicolaidis, S., 87 Niedermauntel, W., 2 15 Niijima, A., 103 Nishino, H., 227, 517 Nogawa, S., 49 Nolan, P. C., 673 Norman, A. B., 493 Nozaki, H., 49 Ocrant, I., 425 Ohya, A., 6 15 Okui, Y., 103 Olson, L., 159 Onimam, H., 65 Ono, T., 227
INDEX
696
Ouerghi, D., 689 Overstreet, D. H., 47 1
Rybosova, Z., 2 I I
Paeile, C., 685 Papa, M., 509 Pavcovich, L. A., 83 Peccia, J. C., 373 Pellicano, M. P., 509 Perez, H., 685 Pohl, M., 107 Popelier, M., 25 I Porter, J. P., 653 Prado-Alcala, R. A., 521 Pucilowski, O., 47 I Pundt, L. L., 97
Sadile, A. G., 503, 509 Sainsbury, R. S., 113 Sakata, T., 555 Sakurai, T., 5 17 Sanberg, P. R., 477,493 Sanchez-Arroyos, R., 17 I Santana, C., 11 Satoda, T., 66 I Saydoff, J. A., 567 Schoorlemmer, G. H. M., 573 Schormair. C.. 329 Schulkin, J., 91 Schwartz, M. W., 379 Seidl, J., 107 Seidler, F. J., 359 Serino, I., 257 Shaffer, M. J., 497 Shah, G., 43 Sharma, R., 153 Shinya, A., 6 I5 Shioda, S., 267 Shirai, T., 49 Shukitt-Hale, B., 385 Sipols, A. J., 379 Slotkin, T. A., 359 Smock, T., 321 Solano-Flares, L. P., 467 Sorensen, C. M., 58 I Soto-Moyano, R., 685 Speckmann, E.-J., 329 Spessert, R., 589 St.-Pierre, S., 487
Quirarte, G. L., 52 I Ramirez, 0. A., 83 Reite, M., 325 Rehon, J. K., 223 Renner, K. J., 293 Reyes, P. F., I Richard. D.. 689 Richardson,’ R. D., 379 Rivest, R., 487 Rochet, T., 6 11 Rockhold, R. W., 26 1 Rodriguez, M., I1 Roozendaal, B., 573 Rothwell, N. J., 223 Rowland, N. E.. 391 Ruiz, S., 685 Ruwe, W. D., 17
Steger, R. W., 399 Stillman, M. J., 385 Stocker, J., 325 Strain, G. M., 57 Strijbos, P. J. L. M., 223 Stuesse, S. L., 195 Suarez, M. G., 1 Surlemont, C., 273 Tabuchi, E., 227 Taguchi, H., 103 Takada, M., 301 Takahashi, A., 593 Takashima, S., 49 Takeuchi, Y., 66 1 Tanaka, K., 49 Tang, J.-S., I79 Tao, S., 407 Tasaka, K., 365 Teale, P., 325 Tedford, B. L., 57 Thibault, J., 123 Thorn, K. J.. 29 Tobet. S. A., 185 Tokunaga, K., 191 Tsuruoka, M., 6 I5 Ueta, Y., 453 Van Der Zee, E. A., 601,623 Vescia, S., 503 Vincens, M.. 25 1 Vollrath, L., 589 Vossen, J. M. H., 7 Vriend, C. Y ., 58 1
Vtiend, J. P., 433 Wadhwa, S., 153 Waldrop, T. G., 673 Wamsley, J. K.. 97 Wan, W., 581 Wang, Q.-P., 3 15 Watanabe, T., 3 I I Wayner, M. J., 467 Wehman, P. J., 443 Welzl. H.. 509 Williams, F. E., 549 Winn, S. R., 477 Wittkowski, W., 329 Woods, S. C.. 379 Wright, D. E., 497 Wright. J. W.. 497 Wu,M., 395 Wurtman, R. J., 667 Yamanouchi, K., 635 Yamashita. H.. 453 Yang, X.-H., 35, 681 Yellon, S. M., 29 Yoshimatsu, H., 555 Zaplana, J., I7 I Zawada, W. M., 17 Zeng, D., 195 Zhang, L., 437 Zhang, T., 26 1 Zhang, W. M.. 21 I Zhao, J.. 477 Zmyslowski, W., 235, 24 I
KEYWORD (-)-Cotinine, 23 (-)-Nicotine, 23 2-Deoxyghlcose, I7 1 5-ADMP, 275 5-HT, 133 5-HTZ, 87 5a-P&mane-3aol-20-one, 25 1 6_Hydroxydopamine, 153 8-(p-sulfophenyl) Theophylline, 407 5,7-Dihydroxytryptamine, 567 [?+TBPS binding, 25 1, 647 (Y-MSH,3 I 1 a-Adrenergic receptors, 97 o-Fluoromethylhistidine (FMH), 555 cut-Receptor, 97 cy,-Subtypes, 97 %A, 97 ozrl, 97 ~ZC> 97 AADC, 123 Acetylchohne, 35, 143, 339, 593 ACTH, 567,6 I 1 Adenosine, 407 Adenylate cyclase in developing brain, 359 Adrenal ahtcocorticoids. 537 Aging, 477 Alzheimer’s disease, 1 Amino acid deficiency, 549 Amino acid imbalance, 549 Amphetamine, 56 1 Amygdala, 301, 339, 561 Aneuploidy, 2 15 Angiotensin II, 497 Anaiotensin IV. 497 A&omycin, 17 Anoxia, 159 Antidepressants, 257 Apomorphine, 7 1, 47 1,487 Arachidonic acid, 437 Arcuate nucleus, 58 I Area postrema, 53 1 Aromatase, 273 Aromatic L-amino acid decarboxylase, 123 Arterial pressure, 673 Atropine, 35 Attention deficit hyperactivity disorder , 159 Auditory-evoked fields, 325 Autoradiographic technique, 25 I Autoradiography, 49, 91, 497 Autoreceptor, 385 fl-Adrenergic receptors, 257 &Carbolines, 647 fi-Endorphin, 26 I B6CBAF,/J vs. C57BL/6J mice, 57 BIllax,49 Baroreceptors, 407 Barrow, 285 Basal ganglia, 35 I Becuculine, 647 Behavioral activity, 573 Behavioral arousal, 509 Behavioral asymmetry, 11 Behavioral effects of neural transnlantation. 493 Behavioral habituation, 509
INDEX
Behavioral interactions, 23 Behavioral supersensitivity, 47 1 Benzodiazepines, 647 Biochemical asymmetry, 1I Bioelectric activity, 329 Blood pressure, 35, 407, 497 Body fat, 2 11 Body temperature, 17, 20 I Bombesin, 629 Brain lesion, 273 Brain neuronal histamine, 555 Brain regions, 68 1 Brain stem. 123. 153. 419. 581. 639 Brain, 35, i91, 215, 379, 567, 593 Buserehn, 689 c-Fos, 447, 509 c-Jun, 509 C-fiber excitabihtv. 685 CAI region, 113 Capsaicin, 685 Cardiorespiratory control, 46 I Cardiovascular, 653 Cat, 235, 241, 639, 673 Catecholamines, 153, 261, 273, 285 CCK, 53 1 CCK-8,453 Central amygdala, 573 Cerebellum, 2 15, 509,6 I5 Cerebral cortex, 107 Cerebral cortex of the rat, 647 Cerebral ischemia, 49, 223, 373 Cervix, 467 cGMP, 589 Choline oxidase, 593 Choline-free plasma (CFP) rat, 593 Cholinesterase inhibition, 68 I Chronic antidepressants, 47 1 Chronic electrophysiology, 32 1 Circadian rhythms, 29,623 Circumventricular organ, 4 I9 Clonidine, 133, 68 1 CNS, 285 Collaterahzation, 30 1 Coordination, 24 1 Copulation, 273 Core body temperatue, 629 Comu ammonis, 17 1 Cot-ticosterone, 573,6 11,629 Corticotropin-releasing factor, 689 Cycle (Asp-Phe), 667 Cycle (His-Pro), 667
D- and L-Nitro-arginine, 43 d-Tubocurarine, 17 1 Decerebration, 46 I Densitometric averages, I7 1 dentata, I7 1 Depth profiles, 113 Desmethyiimipramine, 153 Desipramine, 425,47 1 Development, 29, 107, 159, 2 15 Dexamethasone, effects on development of brain adenylate cyclase, 359 Diabetes. 399 Diabetic’rat, 46 I Diacylglycerol, 437
Discrimination learning, 7 Djungarian, 29 DOPAC, 667 Dopamine, 11, 159, 285, 301, 395, 433, 471, 477,53 I, 667 Dorsal hippocampus, 601 Dorsal medulla, 4 I9 Dorsal motor nucleus of the vagus, 525 Dorsal raphe nucleus, 3 15 Double immunostaining, 3 I5 Double Y-maze, 339 Double-labeling immunocytochemistry, 601 Drinking, 497 Drinking behavior, 26 I Drinking circuit, 39 I Dual lesions, 635 Eating speed, 555 EEG synchronization, 365 Efferent discharges, 103 Electrocoagulation, 365 Electroconvulsive shock, 257 Electron microscopy, 3 15 Enantiomers, 443 Endotoxin, 17 Enkephalin, 3 I5 Entorhinal cortex, I, 17 1 Epilepsy, 329 Epinephrine, 573 Estrogen, 689 Estrogen implants, 293 Ethanol, 23, 43 Evoked potentials, 107 Excitatory amino acids, 223, 673 Excitotoxin models, 493 Excitotoxins, 493 Exercise, 673 Extracellular dehydration, 39 I Facial nerve, 66 I Fascia, 17 1 Feeding, 87, 133, 543,629 Feeding behavior, 379 Female rat, 635 Fetal neural transplantation, 493 Fever of unknown origin, 75 Fever, 17 Fish oil, 223 Flash visual evoked potentials, 57 Flinders sensitive line. 47 1 fluid balance, 207 Fhiorescent tracers, 195 Foliation, 2 I5 Food choice, 543 Food consistency, 555 Food intake, 443,537, 543, 549,689 Fomix, 345 Forskolin, 49 Forskolin, effects on brain adenylate cyclase, 359 FOS, 447 Free choline, 593 Free fatty acids, 629 Fungus, 75 GABA, 143, 315, 517 GABAA receptor, 647
698
GAD, 60 1 Galanin, 379 Gastric branch, 103 Gastric distension, 525 Gastric mechanoreceptors, 525 Gastric vagus, 525 Gender differences. 325 Gene expression, 379, 509 Genetics, 537 Gilt, 285 Globus pallidus, 301, 35 1 Glucose, 53 I Glucose availabilitv. 629 Glucose-responsive neuron, 53 1 Glutamate, 143, 437 Gonadal steroids, 185, 285 Ground squirrel, 379 Guinea pig, 497 Guinea pig brain. 25 1 Haloperiodol, 7 Heart rate, 407, 573, 673 Hemispheric specialization, 325 Hepatic glucoreceptors, 525 Hepatic vagus, 525 Hibernation, 379 Hippocampal slice, I 13 Hippocampus, 171,329, 373,437,497, 509 Histamine, 143, 267, 365 Horseradish peroxidase, 329 Human, 345 Human hippocampus, 25 1 Huntington’s disease, 493 HVA, 667 Hyperphagia, I9 I Hyperthermia, 75 Hypothalamus, 17, 75, 207, 211, 267, 379, 399,425, 537,673 Hypothermia, 373,47 I, 629 ICS 205-930. 549 IL-2, 17 Immediate early genes, 509 Immunocytochemistry, 267, 273,639 Immunohistochemistry, 123 In vitro, 65, 113 In vivo microdialysis, 453 Infarct, 5 17 Inferior olive, 30 I Inflammation, 3 11 Inspiratory neuron, 65 Insulin, 425, 629 Insulin secretion, 46 I Interleukin- I, 17, 3 I 1 Intracellular dehydration, 39 1 Intracellular staining, 329 lntracerebral injection, 75 lntracerebroventricular, 23 Intrathecal, 653 Ischemia, 5 17 Isolation, 6 I I Isoproterenol, 257 K‘j. 49 Lateral cerebral ventricle, 629 Lateral reticular nucleus, 179 Lateral septum, 635 Lateralityi 325 Laterodorsal tegmental nucleus, I95 LC activity, 83 Learned helplessness, 83
INDEX
Learned irrelevance, 7 Lever press, 7 Lipopolysaccharide, 58 I Locomotion, 235, 24 1, 395 Locomotor activity, 47 1, 477, 56 I Locomotor parameters, 235, 241 Long-term DMI treatment, 83 Long-term habituation, 503 Long-term potentiation, 437 Lordosis inhibiting system, 635 Lordosis, 293, 635 Losartan potassium, 39 I Luteinizing hormone, 399 MlOO, 325 m2 Receptor, 385 Macronutrient selection, I33 Macrophage inflammatory protein-l (MIP-I), 17 Magnetic resonance imaging, 345 Magnetoencephalography, 325 Male, 29 Masseter muscle, 6 I5 Mating, 447 Meal duration, 555 Meal size, 555 Medial amygdala, 447 Medial frontoal cortex, I95 Medial preoptic area, 153 Medulla oblongata, 267 MEG, 325 Melatonin, 257, 433 Memory consolidation. 52 1 Memory, 345,497 Mesencephalic central gray, 635 Mesencephalic trigeminal nucleus (Me5), 555 Methoctramine, 385 Mice, 23, 31 1 Microdialysis, 385, 5 17, 667 Microdrive, 32 I Microinjection, 17, 75 Midbrain central grey, 293 Middle cerebral artery, 5 17 Modafinil. 87 Mongolian gerbil, 373 Monkey, 227, 66 1 Monkey cortex, 25 I Monoamines, 123, 159, 185 Monoamines and turnover, 6 11 Morphine, I79 Morphology, 329 Mossy fibers, 437 Motor activity, 509 Motor coordination, 477 Mouse, 2 I5 Mouse brain, 25 1 Mus domeskus, 623 Muscarinic acetylcholine receptor, 601 Muscarinic agonists, 589 Muscarinic receptors, 35, 385, 68 1 N-propylnorapomorphine, 487 NADPH-diaphorase, 207 Neocortex, 301, 509 Neonatal, 1I, 159 Nest-building behavior, 623 Neural grafting, 493 Neural nets, 509 Neuritic plaques, I Neurodegenerative disorders, 493 Neurofibrillary tangles, I Neurogenic fever, 75
Neuronal activity, 227 Neuronal firing, 407 Neuropathology, 1 Neuropeptide Y, 379,46 1 Neuropsychology, 325 Neurosecretion, 207 Neurotensin, 487 Neurotoxin, 273 Neutrophils, 3 1I Newborn rat, 65 Nicotine, 35 Nitric oxide, 43, 7 I NMDA, 65,653 NMDA agonist, 223 NMDA receptors, 43, 509 Nociception, 179 Nonassociative learning, 503 Noradrenaline, 87, 153, 159, 453 Norephedrine, 443 Norepinephrine transporter, 425 Norepinephrine, 133, 273,285, 399, 573, 589 Novelty, 509 Nucleus accumbens, 30 I, 395 Nucleus basalis magnocellularis, 339 Nucleus of the solitary tract, 525 Nucleus tractus solitarius. 407. 46 I ob/ob mice, 133 Obesity, 191, 537 Oleoyl-acetyl-glycerol, 437 Olfactory bulb, 1, 467 Olfactory cortex, 1 Olfactory tubercle, 301 Oncogene proteins, 58 1 Ontogenesis, 647 Operant bar-press behavior, 227 Osmotic, 567 Osmotic minipump, 201 Ovariectomy, 689 Over-reinforcement, 52 I Oxytocin, 7 I, 567, 573 Oxytocin-secreting neurons, 453 p-Aminoclonidine, 97 plodoclonidine, 97 Paraventricular, 207 Paraventricular nucleus, 19I, 453, 58 1, 653 Parkinson’s disease, 493 Parvalbumin, 60 1,639 Passive avoidance conditioning, 497 Passive avoidance learning, 52 I Passive avoidance task, 5 I7 Pattern reversal visual evoked potentials, 57 PD123319, 391 Penile erection, 7 I, 487 Pentylenetetrazol, 329 Peptide, 4 19 Periamygdaloid nucleus, I Periaqueductal gray, 143 Phenylpropanolamine, 443 Pheochromocytoma, 425 Phorbol, 49 Physostigmine, I7 I, 487 Picrotoxin, 25 I Pig, 285 Pineal gland, 257 Pineilia
ternata,
103
Plasma, 593 Pons, 267 Posterior pituitary, 433 Posttrial sleep, 503 Potentiation, 107
699
INDEX
Pre-inspiratory neuron, 65 Preoptic area, 75, 273, 447 Prepirifonn cortex, I Projection, 6 15 Proprioceptive sensation from the oral ca 555 Prostaglandin, 17 Protein Kinase C. 437 Protein synthesis,’ I7 Protooncogene peptides, 509 Puberty, 29 Putamen, 227 Pyrogens, 17, 75
Settraline, 47 1 Sex differences, 11, 9 I, 325 Sexual differentiation, 185 SHR, 261 Single-unit recording, 321 Sleep, 87 Sleep functions, 503 Sleep-wakefulness, 153 Sodium nitrourusside. 589 Somatostatin,* 60 1 Spatial novelty, 503 Spinal cord, 301, 66 1, 673, 685 Spinal lesions, 24 1 Spinal reflex, 685 Quinpirole, 395 Spontaneous hypertension[Sar’,Illes]Angiotensin II, 4 19 Rabbit, 267 Squirrel monkey, 143 Rapid tolerance, 43 Starvation, 543 Rat, 7, 11, 71, 75, 91, 107, 159, 171, 179, 211, Stereotypy, 487 223. 301. 315. 351. 453. 459. 467. 477. 497. Striatum, 49, 30 1, 5 17, 667 Stroke, 223 517; 531; 543; 615; 653; 685 Rat brain, 601 Subnucleus interpolaris, 6 15 Rat pinealocytes, 589 Subparafascicular nucleus, 30 I Reference memory, 339 Substantia nigra, 35 1 Renal nerve, 653 Sucrose, 26 1 Reproductive behavior, 467 Superior cervical ganglion, 66 1 Respiratory rhythm, 65 Superior colliculus, 195 Response strategy, 7 Support patterns, 235, 241 Reticular formation. 179. 365 Suprachiasmatic nucleus, 29, 623 Reticular thalamic nucleus, 35 1 Supraoptic, 207 Retinohypothalamic tract, 29 Supraoptic nucleus, 58 I RNA, 211 Sympathetic activity, 537 RSA, 113 Sympathetic fibers, 66 I Synchronized sleep, 503 Salt preferences, 9 1 Systemic progesterone, 293 Scopolamine, 339 Scopolamine-induced amnesia, 52 I Taste reactivity, 9 1 Second-messenger, 49 Telemetry, 20 1 Self-satisfaction, 543 Temperature, 75 Sensitization, 56 1 Temporal potentiation, 685 Sensory afferent pathway, 467 Temporomandibular joint, 6 15 Serotonin, 159,293, 471, 567 Thalamic afferents, 35 I Serotonim receptor antagonist, 549 Thalamus, 1, 365, 615
Theophylline, 407 Thermoregulation, 17, 75, 629 Theta rhythm, 171 Theta, 113 Thirst, 391 Tilt-plane, 43 Total liver denervation, 549 Transplantation, 5 17 Traumatic brain injury, 345 Trichosooron beiaelii. 75 Trigeminal, 6 I5 Trisomy 19,215 Tropisetron, 549 Tyrosine hydroxylase, 433 Ultrastructue, 267 Under-reinforcement, Uterus, 467
521
Vagina, 467 Vaginocervical stimulation, 447 Vagotomy, 46 1 Vagus nerve, 103 Vasopressin, 207, 567, 573, 623 Ventral septal area, 20 1 Ventrolateral medulla, 65 Ventromedial hypothalamic nucleus (VMH), 555 Ventromedial hypothalamus, 191, 293, 629 Vertebrates, 123 Visual stimulus, 227 Visuomotor, 227 Vocalization, 143 WGA-HRP, 66 1 Windup, 685 Wistar rat, 6 11 Working memory, 339 Yz receptors, 46 1 Yawning, 7 1,487 Zucker obese rat, 555